| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 01/20/2005 | US20050013803 Diagnosing and treating cancer cells using mutant viruses |
| 01/20/2005 | CA2532196A1 Characterization of the earliest stages of the severe acute respiratory syndrome (sars) virus and uses thereof |
| 01/20/2005 | CA2530029A1 Mutant adeno-associated virus virions and methods of use thereof |
| 01/20/2005 | CA2527102A1 Packaged virus-like particles |
| 01/19/2005 | EP1498427A1 Immunoglobulins devoid of light chains |
| 01/19/2005 | EP1498129A1 Use of adenoviruses mutated in the va genes for cancer treatment |
| 01/19/2005 | EP1497468A1 Cells for detection of influenza and parainfluenza viruses |
| 01/19/2005 | EP1497440A2 Stable adenoviral vectors and methods for propagation thereof |
| 01/19/2005 | EP1497421A1 Novel 33 phage vectors |
| 01/19/2005 | EP1497318A2 Binding molecules for fc-region polypeptides |
| 01/19/2005 | EP0804074B1 Treating red blood cell solutions with anti-viral agents |
| 01/19/2005 | CN1566335A Mass preparation of SARS virus capable of meeting the production of inactivated vaccine and inactivation method |
| 01/19/2005 | CN1566334A Novel reovirus, its antibody and vaccine and use thereof |
| 01/19/2005 | CN1566321A Marine bios culturing medium |
| 01/19/2005 | CN1566114A Novel psoralen derivative for annihilating live virus or germ |
| 01/19/2005 | CN1185341C Method for preparing medicine using silkworm expressed human beta interferon |
| 01/19/2005 | CN1185340C Method for producing medicine using silkworm expressed human alpha2b interferon |
| 01/19/2005 | CN1185339C Preparation of cells for producing biological products |
| 01/18/2005 | CA2169603C Retrovirus from the hiv group and its use |
| 01/14/2005 | CA2454540A1 Method for inducing hepatitis c virus (hcv) replication in vitro, cells and cell lines enabling robust hcv replication and kit thereof |
| 01/14/2005 | CA2436104A1 Method for inducing hepatitis c virus (hcv) replication in vitro, cells and cell lines enabling robust hcv replication and kit therefor |
| 01/13/2005 | WO2005003315A2 Compositions and methods for peptide-assisted transfection |
| 01/13/2005 | WO2005002570A1 Use of an aziridino compound to selectively inactivate parasites in biological compositions |
| 01/13/2005 | WO2005002512A2 Immunotherapeutic vaccine strategy |
| 01/13/2005 | WO2004055167A3 Alphavirus particles and methods for preparation |
| 01/13/2005 | US20050010043 Recombinant flavivirus for use in generation of vaccines to prevent and treat hemorrhagic fever |
| 01/13/2005 | US20050009186 Expression vector comprising 3' and 5' long terminal repeats and preferential splice junctions for use as heterologous gene transfer tool; gene therapy |
| 01/13/2005 | US20050009185 Using replication defcetive hepadnaviral plasmid comprising nucleotide sequences coding chemokines and/or cytokines for use in the treatment of liver disorders; tissue engineering and gene therapy |
| 01/13/2005 | US20050009184 Humanised baculovirus |
| 01/13/2005 | US20050009168 Methods and apparatus for Adeno associated virus purification |
| 01/13/2005 | US20050009008 Functional influenza virus-like particles (VLPs) |
| 01/12/2005 | EP1496118A1 Method of measuring human cyp3a inducibility |
| 01/12/2005 | EP1495125A2 Vac-bac shuttle vector system |
| 01/12/2005 | EP1495122A1 Antiviral therapy on the basis of rna interference |
| 01/12/2005 | EP1192245B1 Methods for the propagation of lytic organisms |
| 01/12/2005 | CN1184321C Adenovirus-mediated gene therapy |
| 01/12/2005 | CN1184310C Combined deletion 19 Kda, 55KDA, E1B code sequence recombination adenovirus construction body and its use |
| 01/12/2005 | CN1184235C Chimeric polypeptides, method for production and uses thereof |
| 01/11/2005 | US6841374 Deactivated viral particle for preparing vaccine to prevent flaviviral infection |
| 01/11/2005 | US6841373 Preparing replication defective viral vector for gene transfer tool; genetic engineering |
| 01/11/2005 | US6841364 Infectious cDNA clones of porcine reproductive and respiratory syndrome virus and expression vectors thereof |
| 01/11/2005 | US6841158 Chicken embryo lethal orphan or fowl adenovirus type 1 genome contains a deletion consisting essentially of nucleotides 41,731-43,684 of the wild type |
| 01/11/2005 | US6841157 Wherein early genes are from a first type of papillomavirus and the late genes are from a second papillomavirus |
| 01/11/2005 | CA2033175C Self-assembled, defective, non-self-propagating viral particles |
| 01/06/2005 | WO2005001103A2 Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses |
| 01/06/2005 | WO2005001082A1 Minus strand rna virus vector carrying gene modified in high mutation region |
| 01/06/2005 | WO2005001059A2 Inactivating organisms using carbon dioxide at or near its supercritical pressure and temperature conditions |
| 01/06/2005 | WO2005000881A2 Live attenuated viral vaccines for eastern equine encephalitis virus |
| 01/06/2005 | US20050003507 Method for purifying virus |
| 01/06/2005 | US20050003505 delivering genes; gag genes, gag protein; endothelial growth factor |
| 01/06/2005 | US20050003383 Linoleate isomerase |
| 01/06/2005 | US20050003342 Using polymorphic sequences to identify, classify and monitor viral infection of horses; animal husbandry and veterinary medicine; genetic vaccines; immunotherapy |
| 01/06/2005 | US20050002968 Flavivirus vaccines |
| 01/06/2005 | US20050002966 Attenuated pestiviruses |
| 01/06/2005 | US20050002965 Recombinant adenovirus with enhanced therapeutic effect and pharmaceutical composition comprising said recombinant adenovirus |
| 01/06/2005 | US20050002953 Recombinant vectors expressing E, M and/or S proteins; cell line |
| 01/06/2005 | US20050002908 Method for producing a recombinant adeno-associated virus, suitable means therefor and use for producing a medicament |
| 01/06/2005 | US20050002903 Gene delivery system and methods of use |
| 01/06/2005 | CA2528511A1 Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses |
| 01/06/2005 | CA2527636A1 Live attenuated viral vaccines for eastern equine encephalitis virus |
| 01/05/2005 | EP1492891A1 Methods of virus production |
| 01/05/2005 | EP1492890A2 Large scale methods of producing adenovirus and adenovirus seed stocks |
| 01/05/2005 | EP1492562A2 Virus-like particles of human papillomavirus |
| 01/05/2005 | EP1152773B1 Methods of inactivating pathogens using broad-spectrum pulsed light |
| 01/05/2005 | CN2668642Y Virus liquid concentrating device |
| 01/05/2005 | CN1560248A Tiantan remocined vaccine virus of IFN-alpha receptor gene (B8R) deletion and application thereof |
| 01/05/2005 | CN1183257C Gene transfer method |
| 01/05/2005 | CN1183250C Virus with specigic reproduction in tumor well and effective expression of tumor angiogenesis nihibitory factor and its construction method |
| 01/05/2005 | CN1182901C Purification method and tower, and liquid separating tower tray therefor |
| 01/04/2005 | US6838285 Generation of adenoviral vectors; obtain nucleotide sequences, incubate with vector, expose to recombinases, recover vector |
| 01/04/2005 | US6838279 DNA having a deletion in both copies of the LAT gene and ICP34.5 gene are inserted into the malignant cell |
| 01/04/2005 | US6838272 Filtration process for separating viruses |
| 01/04/2005 | US6838084 For connection with major histomcompatability complex molecules |
| 01/04/2005 | US6837318 Rescue and exploration apparatus |
| 12/30/2004 | US20040268442 Transforming tobacco cell line containing sequences encoding antigens (such as hemagglutinin/neuraminidase protein from Newcastle Disease Virus), culturing, washing, suspending in lysis buffer, disrupting cells, then separating debris; vaccines |
| 12/30/2004 | US20040266007 Modified viral particle for use in expression, isolation and purification of immmoglobulins |
| 12/30/2004 | US20040265986 Method for the recovery and purification of poxviruses from infected cells |
| 12/30/2004 | US20040265856 5' portion of an intestinal lactase-phlorizine hydrolase (LPH) gene; point mutations; solid phase synthesis; immunoassay; vectors; primers; host cells; antibodies; kits; gene therapy |
| 12/30/2004 | US20040265798 expression cassettes including nucleic acid elements for enhancing the titer of pseudotyped viral particles; heterologous envelope glycoprotein derived from a Jaagsiekte sheep retrovirus (JSRV env); use in gene therapy |
| 12/30/2004 | US20040265339 Infectious bronchitis virus vaccine |
| 12/30/2004 | US20040265338 Contain large deletions; vaccines against dengue virus infection; structural proteins encapsulate said subgenomic replicon |
| 12/30/2004 | US20040265336 Multivalent vaccination using recombinant adenovirus |
| 12/30/2004 | US20040265326 Culturing respiratory syncytial virus on cells in a culture medium; separating grown virus from culture medium; solubilizing at least fusion (F) protein, attachment (G) protein and matrix (M) protein from the separated virus; coisolating ,copurifying solubilized RSV proteins; immunogenic |
| 12/30/2004 | US20040265320 Administering a compound selected from 3-O-(3',3'-dimethylsuccinyl) betulinic acid, 3-O-(3',3'-dimethylsuccinyl) betulin, 3-O-(3',3'-dimethylglutaryl) betulin, 3-O-(3',3'-dimethylsuccinyl) dihydrobetulinic acid, 3-O-(3',3'-dimethylglutaryl) betulinic acid, (3',3'-dimethylglutaryl) dihydrobetulinic acid |
| 12/30/2004 | US20040265271 Reovirus for the treatment of neoplasia |
| 12/29/2004 | WO2004113518A1 Improvements in virus production |
| 12/29/2004 | WO2004113517A2 IMPROVED METHOD FOR THE RECOVERY OF NON-SEGMENTED, NEGATIVE-STRANDED RNA VIRUSES FROM cDNA |
| 12/29/2004 | WO2004113494A2 Methods for producing preparations of recombinant aav virions substantially free of empty capsids |
| 12/29/2004 | WO2004112707A2 Method for purifying virus |
| 12/29/2004 | WO2003087128A3 Secretory signal sequences and uses thereof |
| 12/29/2004 | WO2003057178A3 Viral capsid assembly intermediates |
| 12/29/2004 | EP1491631A1 Method of screening transporter inhibitor |
| 12/29/2004 | EP1491556A1 Humanized immunoglobulins and their production and use |
| 12/29/2004 | EP1491210A1 Therapeutic drug using antibody-presenting hollow protein nanoparticles and hollow protein nanoparticles |
| 12/29/2004 | EP1490389A2 Hepatitis c virus sub-genomic replicons |
| 12/29/2004 | EP1196616B1 Replication-competent anti-cancer vectors |
| 12/29/2004 | EP1090033B1 Particles of hcv envelope proteins: use for vaccination |
| 12/29/2004 | EP1084251B1 Attenuated pestiviruses |
| 12/29/2004 | EP1064393B1 Compositions and methods for helper-free production of recombinant adeno-associated viruses |
| 12/29/2004 | EP0785946B1 Materials for the production of nanometer structures and use thereof |